Detalles de la búsqueda
1.
Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.
Am Heart J
; 258: 119-128, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592878
2.
Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
Am Heart J
; 262: 75-82, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37088164
3.
Prehospital Tirofiban Increases the Rate of Disrupted Myocardial Infarction in Patients with ST-Segment Elevation Myocardial Infarction: Insights From the On-TIME 2 Trial.
Eur Heart J Acute Cardiovasc Care
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38845559
4.
Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
Thromb Haemost
; 123(2): 150-158, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075236
5.
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
J Am Heart Assoc
; 12(24): e031855, 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38063187
6.
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
EuroIntervention
; 18(4): e303-e313, 2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35370126
7.
Optimizing Antiplatelet Pretreatment in STEMI: The Crucial Role of Timing and Agent Selection.
JACC Cardiovasc Interv
; 17(6): 820-821, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538177
Resultados
1 -
7
de 7
1
Próxima >
>>